News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

bluebird bio To Host A Conference Call To Discuss Initial Results From The HGB-205 Study In Beta-Thalassemia Major Subjects


6/10/2014 6:45:43 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

bluebird bio, Inc. (Nasdaq: BLUE), a clinical-stage company committed to developing potentially transformative gene therapies for severe genetic and orphan diseases, today announced it was hosting a conference call to review the initial results from the HGB-205 Study to be presented on Saturday June 14, 2014 at 04:15 pm CET (10.15 am EDT) at the 19th Annual Congress of the European Hematology Association (EHA) in Milan, Italy.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES